1-8 of 8
Eunice S. Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT162: Addition of parsaclisib (INCB050465), a PI3Kδ inhibitor, in patients with suboptimal response to ruxolitinib: A phase 2 study in patients with myelofibrosis

Abdulraheem Yacoub, Eunice S. Wang, Raajit K. Rampal, Uma Borate, Marina Kremyanskaya, Haris Ali, Gabriela S. Hobbs, Casey O'Connell, Albert Assad, Sue Erickson-Viitanen, Feng Zhou, Timothy C. Burn, Naval G. Daver
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT162.
https://doi.org/10.1158/1538-7445.AM2021-CT162
Published: 01 July 2021
View article titled, Abstract CT162: Addition of parsaclisib (INCB050465), a PI3Kδ inhibitor, in patients with suboptimal response to ruxolitinib: A phase 2 study in patients with myelofibrosis
Journal Articles

Abstract 2820: Synergistic antileukemic activity of the antibody-drug conjugate (IMGN779) combined with PARP inhibition in preclinical human acute myeloid leukemia models

Claire Fritz, Scott M. Portwood, Julie Adams, Eunice S. Wang
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2820.
https://doi.org/10.1158/1538-7445.AM2018-2820
Published: 01 July 2018
View article titled, Abstract 2820: Synergistic antileukemic activity of the antibody-drug conjugate (IMGN779) combined with PARP inhibition in preclinical human acute myeloid leukemia models
Journal Articles

Abstract 2864: Inhibition of the late stages of autophagy overcomes hypoxia-induced chemoresistance and targets leukemic stem cells in acute myeloid leukemia

Kaitlyn M. Dykstra, Dirkje W. Hanekamp, Matthew Johnson, Monica L. Guzman, Eunice S. Wang
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2864.
https://doi.org/10.1158/1538-7445.AM2018-2864
Published: 01 July 2018
View article titled, Abstract 2864: Inhibition of the late stages of autophagy overcomes hypoxia-induced chemoresistance and targets leukemic stem cells in acute myeloid leukemia
Journal Articles

Abstract CT129: The THINK clinical trial: Preliminary evidence of clinical activity of NKG2D chimeric antigen receptor T cell therapy (CYAD-01) in acute myeloid leukemia

David A. Sallman, Jason B. Brayer, Xavier Poire, Tessa Kerre, Philippe Lewalle, Eunice S. Wang, Bikash Verma, Eytan Breman, Marco Davila, Nathalie Braun, Caroline Lonez, David E. Gilham, Frédéric F. Lehmann
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): CT129.
https://doi.org/10.1158/1538-7445.AM2018-CT129
Published: 01 July 2018
View article titled, Abstract CT129: The THINK clinical trial: Preliminary evidence of clinical activity of NKG2D chimeric antigen receptor T cell therapy (CYAD-01) in acute myeloid leukemia
Journal Articles

Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs

Elimelech Nesher, Alfiya Safina, Ieman Aljahdali, Scott Portwood, Eunice S. Wang, Igor Koman, Jianmin Wang, Katerina V. Gurova
Journal: Cancer Research
Cancer Res (2018) 78 (6): 1431–1443.
https://doi.org/10.1158/0008-5472.CAN-17-2690
Published: 14 March 2018
View article titled, Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs
Open the PDF for Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs in another window
Includes: Supplementary data
Journal Articles

Abstract 5459: Preclinical efficacy of the novel PIM2 kinase inhibitor, JP_11646, in human acute leukemia models

Krista E. Pundt, Carmen M. Baldino, Justin Caserta, Stephane Dumas, Yvonne Flanders, Eunice S. Wang, Gerald J. Fetterly
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 5459.
https://doi.org/10.1158/1538-7445.AM2014-5459
Published: 01 October 2014
View article titled, Abstract 5459: Preclinical efficacy of the novel PIM2 kinase inhibitor, JP_11646, in human acute leukemia models
Journal Articles

Abstract 5463: Development of a pharmacokinetic (PK)-pharmacodynamic (PD) model to guide combination-dosing strategies of aflibercept (VEGF Trap) and doxorubicin chemotherapy in a systemic preclinical model of human acute myeloid leukemia

Urvi Telang Aras, Deepika Lal, Patricia Zagst, Gerald J. Fetterly, Eunice S. Wang
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 5463.
https://doi.org/10.1158/1538-7445.AM2011-5463
Published: 15 April 2011
View article titled, Abstract 5463: Development of a pharmacokinetic (PK)-pharmacodynamic (PD) model to guide combination-dosing strategies of aflibercept (VEGF Trap) and doxorubicin chemotherapy in a systemic preclinical model of human acute myeloid leukemia
Journal Articles

Abstract 3581: Investigation of the mechanism of aflibercept mediated modulation of doxorubicin anti-tumor effects in a preclinical model of leukemia: Development of a pharmacokinetic-pharmacodynamic model to guide combination dosing strategies

Urvi Telang, Deepika Lal, Patricia D. Zagst, Gerald J. Fetterly, Eunice S. Wang
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3581.
https://doi.org/10.1158/1538-7445.AM10-3581
Published: 15 April 2010
View article titled, Abstract 3581: Investigation of the mechanism of aflibercept mediated modulation of doxorubicin anti-tumor effects in a preclinical model of leukemia: Development of a pharmacokinetic-pharmacodynamic model to guide combination dosing strategies